Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Gosford, Australia, 2076
- TG Therapeutics Investigational Trial Site
-
-
New South Wales
-
Gosford, New South Wales, Australia, 02250
- TG Therapeutics Investigational Trial Site
-
Wahroonga, New South Wales, Australia, 02076
- TG Therapeutics Investigational Trial Site
-
-
Queensland
-
Benowa, Queensland, Australia, 04217
- TG Therapeutics Investigational Trial Site
-
South Brisbane, Queensland, Australia, 04101
- TG Therapeutics Investigational Trial Site
-
-
South Australia
-
Adelaide, South Australia, Australia, 05000
- TG Therapeutics Investigational Trial Site
-
-
Victoria
-
Heidelberg, Victoria, Australia, 03084
- TG Therapeutics Investigational Trial Site
-
-
Western Australia
-
Nedlands, Western Australia, Australia, 06009
- TG Therapeutics Investigational Trial Site
-
Netherlands, Western Australia, Australia, 06009
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Ashkelon, Israel, 7830604
- TG Therapeutics Investigational Trial Site
-
Be'er Sheva, Israel, 8410101
- TG Therapeutics Investigational Trial Site
-
Haifa, Israel, 91031
- TG Therapeutics Investigational Trial Site
-
Jerusalem, Israel, 9112001
- TG Therapeutics Investigational Trial Site
-
Nahariya, Israel, 2210001
- TG Therapeutics Investigational Trial Site
-
Petah Tikva, Israel, 49100
- TG Therapeutics Investigational Trial Site
-
Tel Aviv, Israel, 64239
- TG Therapeutics Investigational Trial Site
-
Tel Aviv, Israel, 6971028
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Bologna, Italy, 40138
- TG Therapeutics Investigational Trial Site
-
Ferrara, Italy, 44020
- TG Therapeutics Investigational Trial Site
-
Milan, Italy, 20132
- TG Therapeutics Investigational Trial Site
-
Milan, Italy, 20141
- TG Therapeutics Investigational Trial Site
-
Rome, Italy, 00161
- TG Therapeutics Investigational Trial Site
-
Torino, Italy, 10126
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Busan, Korea, Republic of, 47392
- TG Therapeutics Investigational Trial Site
-
Busan, Korea, Republic of, 49241
- TG Therapeutics Investigational Trial Site
-
Gyeonggi-do, Korea, Republic of, 13620
- TG Therapeutics Investigational Trial Site
-
Incheon, Korea, Republic of, 21565
- TG Therapeutics Investigational Trial Site
-
Seoul, Korea, Republic of, 03080
- TG Therapeutics Investigational Trial Site
-
Seoul, Korea, Republic of, 06351
- TG Therapeutics Investigational Trial Site
-
Seoul, Korea, Republic of, 06591
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Chorzów, Poland, 41-500
- TG Therapeutics Investigational Trial Site
-
Gdynia, Poland, 81-519
- TG Therapeutics Investigational Trial Site
-
Kraków, Poland, 30-510
- TG Therapeutics Investigational Trial Site
-
Lublin, Poland, 20-090
- TG Therapeutics Investigational Trial Site
-
Słupsk, Poland, 76-200
- TG Therapeutics Investigational Trial Site
-
Warszawa, Poland, 02-781
- TG Therapeutics Investigational Trial Site
-
Warszawa, Poland, 02-106
- TG Therapeutics Investigational Trial Site
-
Wrocław, Poland, 50-367
- TG Therapeutics Investigational Trial Site
-
Łódź, Poland, 93-513
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Bratislava, Slovakia, 81250
- TG Therapeutics Investigational Trial Site
-
Bratislava, Slovakia, 83310
- TG Therapeutics Investigational Trial Site
-
Košice, Slovakia, 04191
- TG Therapeutics Investigational Trial Site
-
Poprad, Slovakia, 05801
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Barcelona, Spain, 08035
- TG Therapeutics Investigational Trial Site
-
Barcelona, Spain, 08041
- TG Therapeutics Investigational Trial Site
-
Madrid, Spain, 28041
- TG Therapeutics Investigational Trial Site
-
Madrid, Spain, 28222
- TG Therapeutics Investigational Trial Site
-
Salisbury, Spain, 37007
- TG Therapeutics Investigational Trial Site
-
Valencia, Spain, 46010
- TG Therapeutics Investigational Trial Site
-
-
-
-
-
Cambridge, United Kingdom, CB2-0QQ
- TG Therapeutics Investigational Trial Site
-
Denmark Hill, United Kingdom, SE5-9RS
- TG Therapeutics Investigational Trial Site
-
Leeds, United Kingdom, LS97TF
- TG Therapeutics Investigational Trial Site
-
Liverpool, United Kingdom, L7-8XP
- TG Therapeutics Investigational Trial Site
-
London, United Kingdom, SW170QT
- TG Therapeutics Investigational Trial Site
-
London, United Kingdom, EC1A-7BE
- TG Therapeutics Investigational Trial Site
-
Oxford, United Kingdom, OX37LE
- TG Therapeutics Investigational Trial Site
-
Plymouth, United Kingdom, PL68DH
- TG Therapeutics Investigational Trial Site
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35243
- TG Therapeutics Investigational Trial Site
-
Huntsville, Alabama, United States, 35805
- TG Therapeutics Investigational Trial Site
-
-
Arizona
-
Chandler, Arizona, United States, 85224
- TG Therapeutics Investigational Trial Site
-
Tucson, Arizona, United States, 85711
- TG Therapeutics Investigational Trial Site
-
Tucson, Arizona, United States, 85724
- TG Therapeutics Investigational Trial Site
-
-
California
-
Los Angeles, California, United States, 90095
- TG Therapeutics Investigational Trial Site
-
Orange, California, United States, 92868
- TG Therapeutics Investigational Trial Site
-
San Diego, California, United States, 92108
- TG Therapeutics Investigational Trial Site
-
San Diego, California, United States, 90710
- TG Therapeutics Investigational Trial Site
-
Whittier, California, United States, 90603
- TG Therapeutics Investigational Trial Site
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- TG Therapeutics Investigational Trial Site
-
Denver, Colorado, United States, 80218
- TG Therapeutics Investigational Trial Site
-
Fort Collins, Colorado, United States, 80528
- TG Therapeutics Investigational Trial Site
-
-
Connecticut
-
Bridgeport, Connecticut, United States, 06606
- TG Therapeutics Investigational Trial Site
-
-
Delaware
-
Newark, Delaware, United States, 19713
- TG Therapeutics Investigational Trial Site
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- TG Therapeutics Investigational Trial Site
-
-
Florida
-
Boca Raton, Florida, United States, 33486
- TG Therapeutics Investigational Trial Site
-
Fort Myers, Florida, United States, 33916
- TG Therapeutics Investigational Trial Site
-
Gainesville, Florida, United States, 32608
- TG Therapeutics Investigational Trial Site
-
Jacksonville, Florida, United States, 32224
- TG Therapeutics Investigational Trial Site
-
Jacksonville, Florida, United States, 32204
- TG Therapeutics Investigational Trial Site
-
Jacksonville, Florida, United States, 32256
- TG Therapeutics Investigational Trial Site
-
Miami, Florida, United States, 33176
- TG Therapeutics Investigational Trial Site
-
Saint Petersburg, Florida, United States, 33705
- TG Therapeutics Investigational Trial Site
-
Tallahassee, Florida, United States, 32308
- TG Therapeutics Investigational Trial Site
-
Tampa, Florida, United States, 33612
- TG Therapeutics Investigational Trial Site
-
West Palm Beach, Florida, United States, 33407
- TG Therapeutics Investigational Trial Site
-
-
Georgia
-
Albany, Georgia, United States, 31701
- TG Therapeutics Investigational Trial Site
-
Macon, Georgia, United States, 31201
- TG Therapeutics Investigational Trial Site
-
Marietta, Georgia, United States, 30060
- TG Therapeutics Investigational Trial Site
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- TG Therapeutics Investigational Trial Site
-
Chicago, Illinois, United States, 60637
- TG Therapeutics Investigational Trial Site
-
Decatur, Illinois, United States, 62526
- TG Therapeutics Investigational Trial Site
-
Evanston, Illinois, United States, 60201
- TG Therapeutics Investigational Trial Site
-
Harvey, Illinois, United States, 60426
- TG Therapeutics Investigational Trial Site
-
Maywood, Illinois, United States, 60153
- TG Therapeutics Investigational Trial Site
-
Niles, Illinois, United States, 60714
- TG Therapeutics Investigational Trial Site
-
Peoria, Illinois, United States, 61615
- TG Therapeutics Investigational Trial Site
-
Swansea, Illinois, United States, 62226
- TG Therapeutics Investigational Trial Site
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46845
- TG Therapeutics Investigational Trial Site
-
Indianapolis, Indiana, United States, 46237
- TG Therapeutics Investigational Trial Site
-
-
Kansas
-
Westwood, Kansas, United States, 66210
- TG Therapeutics Investigational Trial Site
-
-
Kentucky
-
Louisville, Kentucky, United States, 40207
- TG Therapeutics Investigational Trial Site
-
-
Louisiana
-
Covington, Louisiana, United States, 70433
- TG Therapeutics Investigational Trial Site
-
-
Maine
-
Brewer, Maine, United States, 04412
- TG Therapeutics Investigational Trial Site
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- TG Therapeutics Investigational Trial Site
-
Bethesda, Maryland, United States, 20817
- TG Therapeutics Investigational Trial Site
-
Columbia, Maryland, United States, 21044
- TG Therapeutics Investigational Trial Site
-
Towson, Maryland, United States, 21204
- TG Therapeutics Investigational Trial Site
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- TG Therapeutics Investigational Trial Site
-
-
Minnesota
-
Duluth, Minnesota, United States, 55805
- TG Therapeutics Investigational Trial Site
-
Saint Louis Park, Minnesota, United States, 55416
- TG Therapeutics Investigational Trial Site
-
-
Missouri
-
Columbia, Missouri, United States, 65212
- TG Therapeutics Investigational Trial Site
-
Kansas City, Missouri, United States, 64132
- TG Therapeutics Investigational Trial Site
-
Saint Louis, Missouri, United States, 63110
- TG Therapeutics Investigational Trial Site
-
-
Montana
-
Billings, Montana, United States, 59102
- TG Therapeutics Investigational Trial Site
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68510
- TG Therapeutics Investigational Trial Site
-
Omaha, Nebraska, United States, 68130
- TG Therapeutics Investigational Trial Site
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- TG Therapeutics Investigational Trial Site
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- TG Therapeutics Investigational Trial Site
-
Morristown, New Jersey, United States, 07962
- TG Therapeutics Investigational Trial Site
-
Mount Holly, New Jersey, United States, 08060
- TG Therapeutics Investigational Trial Site
-
-
New Mexico
-
Farmington, New Mexico, United States, 87401
- TG Therapeutics Investigational Trial Site
-
-
New York
-
Bronx, New York, United States, 10467
- TG Therapeutics Investigational Trial Site
-
Buffalo, New York, United States, 14263
- TG Therapeutics Investigational Trial Site
-
New York, New York, United States, 10019
- TG Therapeutics Investigational Trial Site
-
Syracuse, New York, United States, 13210
- TG Therapeutics Investigational Trial Site
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28201
- TG Therapeutics Investigational Trial Site
-
Durham, North Carolina, United States, 27705
- TG Therapeutics Investigational Trial Site
-
Hickory, North Carolina, United States, 28602
- TG Therapeutics Investigational Trial Site
-
Kinston, North Carolina, United States, 28501
- TG Therapeutics Investigational Trial Site
-
Raleigh, North Carolina, United States, 27607
- TG Therapeutics Investigational Trial Site
-
Washington, North Carolina, United States, 27889
- TG Therapeutics Investigational Trial Site
-
-
Ohio
-
Canton, Ohio, United States, 44718
- TG Therapeutics Investigational Trial Site
-
Cincinnati, Ohio, United States, 45220
- TG Therapeutics Investigational Trial Site
-
Cincinnati, Ohio, United States, 45242
- TG Therapeutics Investigational Trial Site
-
Cleveland, Ohio, United States, 44106
- TG Therapeutics Investigational Trial Site
-
Columbus, Ohio, United States, 43219
- TG Therapeutics Investigational Trial Site
-
Toledo, Ohio, United States, 43623
- TG Therapeutics Investigational Trial Site
-
-
Oregon
-
Portland, Oregon, United States, 97227
- TG Therapeutics Investigational Trial Site
-
Portland, Oregon, United States, 97213
- TG Therapeutics Investigational Trial Site
-
Springfield, Oregon, United States, 97477
- TG Therapeutics Investigational Trial Site
-
-
Pennsylvania
-
Camp Hill, Pennsylvania, United States, 17011
- TG Therapeutics Investigational Trial Site
-
Philadelphia, Pennsylvania, United States, 19106
- TG Therapeutics Investigational Trial Site
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- TG Therapeutics Investigational Trial Site
-
-
South Carolina
-
Greenville, South Carolina, United States, 29615
- TG Therapeutics Investigational Trial Site
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- TG Therapeutics Investigational Trial Site
-
Watertown, South Dakota, United States, 57201
- TG Therapeutics Investigational Trial Site
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- TG Therapeutics Investigational Trial Site
-
Kingsport, Tennessee, United States, 37660
- TG Therapeutics Investigational Trial Site
-
Knoxville, Tennessee, United States, 37916
- TG Therapeutics Investigational Trial Site
-
Memphis, Tennessee, United States, 38120
- TG Therapeutics Investigational Trial Site
-
-
Texas
-
Austin, Texas, United States, 78705
- TG Therapeutics Investigational Trial Site
-
Dallas, Texas, United States, 75390
- TG Therapeutics Investigational Trial Site
-
Fort Sam Houston, Texas, United States, 78234
- TG Therapeutics Investigational Trial Site
-
Houston, Texas, United States, 77030
- TG Therapeutics Investigational Trial Site
-
San Antonio, Texas, United States, 78229
- TG Therapeutics Investigational Trial Site
-
San Antonio, Texas, United States, 78217
- TG Therapeutics Investigational Trial Site
-
San Antonio, Texas, United States, 78130
- TG Therapeutics Investigational Trial Site
-
Tyler, Texas, United States, 75702
- TG Therapeutics Investigational Trial Site
-
-
Utah
-
Ogden, Utah, United States, 84403
- TG Therapeutics Investigational Trial Site
-
-
Virginia
-
Blacksburg, Virginia, United States, 24060
- TG Therapeutics Investigational Trial Site
-
Newport News, Virginia, United States, 23601
- TG Therapeutics Investigational Trial Site
-
-
Washington
-
Olympia, Washington, United States, 98502
- TG Therapeutics Investigational Trial Site
-
Seattle, Washington, United States, 98109
- TG Therapeutics Investigational Trial Site
-
Seattle, Washington, United States, 98104
- TG Therapeutics Investigational Trial Site
-
Seattle, Washington, United States, 98108
- TG Therapeutics Investigational Trial Site
-
Spokane, Washington, United States, 99216
- TG Therapeutics Investigational Trial Site
-
Vancouver, Washington, United States, 97277
- TG Therapeutics Investigational Trial Site
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- TG Therapeutics Investigational Trial Site
-
Wauwatosa, Wisconsin, United States, 53226
- TG Therapeutics Investigational Trial Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of Non-Hodgkin's Lymphoma including Follicular, Mantle Cell Lymphoma and Marginal Zone Lymphoma
- Relapsed or refractory to prior standard therapy and subjects who are not candidates for high-dose therapy or autologous stem cell transplant
- MCL subjects with one or more lines of therapy including at least one BTK inhibitor (ibrutinib, acalabrutinib or zanibrutinib only)
Exclusion Criteria:
- Any major surgery, chemotherapy or immunotherapy within the last 21 days
- Evidence of hepatitis B virus, hepatitis C virus or known HIV infection
- Autologous hematologic stem cell transplant within 6 months of study entry. Prior Allogeneic hematologic stem cell transplant is excluded
- Prior therapy with a PI3K delta inhibitor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Umbralisib + Ublituximab
Umbralisib oral daily dose in combination with Ublituximab intravenous administration
|
Other Names:
Other Names:
|
|
EXPERIMENTAL: Umbralisib
Umbralisib oral daily dose
|
Other Names:
|
|
EXPERIMENTAL: Umbralisib + Ublituximab + Bendamustine
Umbralisib oral daily dose in combination with Ublituximab intravenous administration and Bendamustine intravenous administration
|
Other Names:
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Overall Response Rate
Time Frame: Every 8-12 weeks, up to 2 years
|
Every 8-12 weeks, up to 2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Progression-Free Survival
Time Frame: From date of randomization until the date of first documented progression, assessed up through 2 years
|
From date of randomization until the date of first documented progression, assessed up through 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Owen A O'Connor, MD, PhD, Columbia University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Immune System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Lymphoproliferative Disorders
- Lymphatic Diseases
- Immunoproliferative Disorders
- Leukemia, Lymphoid
- Leukemia
- Leukemia, B-Cell
- Lymphoma, B-Cell
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphoma, Mantle-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Molecular Mechanisms of Pharmacological Action
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Alkylating Agents
- Bendamustine Hydrochloride
Other Study ID Numbers
Other Study ID Numbers
- UTX-TGR-205
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.